Table 1 Comparison of patient’s characteristics between groups of treatment
From: GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
AH | AHT1 | AHT2 | ||
|---|---|---|---|---|
Mean age group < 35 | 33,4 ± 1,7 | 33,7 ± 1,3 | 32,8 ± 1,7 | NS |
Mean age group ≥35 | 38,6 ± 2,3 | 38,1 ± 2,4 | 38,9 ± 2,1 | NS |
% nulliparous | 73,4% | 71,8% | 74,1% | NS |
% male factor | 24,9% | 27,1% | 22,6% | NS |
% tubal factor | 12,3% | 12,7% | 14,0% | NS |
% mixed factor or no factor | 62,8% | 60,2% | 63,4% | NS |
Mean BMI group < 35 | 22,3 ± 2,8 | 23,1 ± 2,6 | 22,1 ± 3,3 | NS |
Mean BMI group > 35 | 24,3 ± 3,7 | 24,2 ± 3,4 | 24,5 ± 3,5 | NS |